داروسازی تهران شیمی
شتهران | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Closed
Last Price: 1,000 0.00
Close Price: 6,830
Cash Flow
AGM
Interim
2026/04/29 Fiscal Year 2025/12/2112 Month / Audited | ||
|---|---|---|
Cash Generated from Operations | 5.303 Trillion | |
Income Taxes Paid | -8.306 Billion | |
Net Cash Flow from Operating Activities | 4.843 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 17.66 Billion | |
Purchases of Property, Plant and Equipment | -6.639 Trillion | |
Purchases of Intangible Assets | -24.21 Billion | |
Cash Paid to Acquire Long-Term Investments | -791.9 Billion | |
Cash Paid to Acquire Short-Term Investments | -11.408 Trillion | |
Dividends Received | 1.074 Billion | |
Cash Received from Income on Other Investments | 2.837 Trillion | |
Net Cash Flow from Investing Activities | -16.007 Trillion | |
Net Cash Flow before Financing Activities | 3.956 Trillion | |
Cash Received from Borrowings | 96.395 Trillion | |
Repayments of Borrowings (Principal) | -67.672 Trillion | |
Interest Paid on Borrowings | -12.787 Trillion | |
Dividends Paid | -200.908 Billion | |
Net Cash Flow from Financing Activities | 15.734 Trillion | |
Net Increase (Decrease) in Cash | 4.57 Trillion | |
Cash at Beginning of Period | 7.274 Trillion | |
Effect of Exchange Rate Changes | 47.928 Billion | |
Cash at End of Period | 7.322 Trillion | |
Non-Cash Transactions | 2.618 Trillion |